InvestorsHub Logo
Followers 33
Posts 5040
Boards Moderated 4
Alias Born 04/05/2017

Re: carp302 post# 23576

Monday, 01/08/2018 9:39:38 PM

Monday, January 08, 2018 9:39:38 PM

Post# of 33257
ENDV definitely knew the acquisition was in process. I had previously posted a Rio Grande PR that stated ENDV was going to purchase the PEMF assets (though the PR did not specifically mention ENDV it did hint at it due to the mention of the previous failed acquisition).

We can only hope ENDV can multitask with the their Immunotronics and the new technology.

While the heart result finalization is pending, ENDV management can be actively working to get the people clinical trial started with Theracap. This is one of the low hanging fruit from RGN. RGN had it all set up but never got it going for whatever reason (probably monetary).

I bet one of those 2 items will be the next PR, unless they unveil a new marketing strategy for Sofpulse. It's on the market now, but could use marketing assistance (not only a Tweet....hehe).

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News